Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Diclofenac for Noncyclic Breast Pain
NCT00276419Phase 3Terminated
- Sponsor
- Mayo Clinic
- Start
- Jun 2005
- Primary completion
- May 2009
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in mastalgia and breast pain (2 arms), sponsored by Mayo Clinic. Primary endpoints: Frequency of Breast Pain at 10 weeks and Severity of Breast Pain at 10 weeks. Started Jun 2005; status: terminated.
02
Drugs
diclofenac
03
Conditions
mastalgiabreast pain
Beyond the preview
Go deeper on NCT00276419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276419.